103
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Chromatin Architecture Around Stroke Haplotypes Provides Evidence that Genetic Risk is Conferred Through Vascular Cells

ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 243-259 | Received 13 Aug 2021, Accepted 28 Jan 2022, Published online: 21 Feb 2022

References

  • Collaborators GBDS . Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol.18(5), 439–458 (2019).
  • Boehme AK , EsenwaC , ElkindMS. Stroke Risk Factors, Genetics, and Prevention. Circ. Res.120(3), 472–495 (2017).
  • Yu S , SuZ , MiaoJet al. Different Types of Family History of Stroke and Stroke Risk: Results Based on 655,552 Individuals. J. Stroke and Cerebrovasc. Dis.28(3), 587–594 (2019).
  • Huang HD , YangCM , ShuHFet al. Genetic predisposition of stroke: understanding the evolving landscape through meta-analysis. Int. J. Clin. Exp. Med.8(1), 1315–1323 (2015).
  • Malik R , DauT , GonikMet al. Common coding variant in SERPINA1 increases the risk for large artery stroke. Proc. Natl Acad. Sci. USA114(14), 3613–3618 (2017).
  • Network NSG , International Stroke Genetics C. Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol.15(2), 174–184 (2016).
  • International Stroke Genetics C , Wellcome Trust Case Control C, BellenguezCet al.Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat. Genet.44(3), 328–333 (2012).
  • Malik R , TraylorM , PulitSLet al. Low-frequency and common genetic variation in ischemic stroke: The METASTROKE collaboration. Neurology86(13), 1217–1226 (2016).
  • Gudbjartsson DF , HolmH , GretarsdottirSet al. A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. Nat. Genet.41(8), 876–878 (2009).
  • Pulit SL , WengLC , McardlePFet al. Atrial fibrillation genetic risk differentiates cardioembolic stroke from other stroke subtypes. Neurol. Genet.4(6), e293 (2018).
  • Traylor M , MalikR , NallsMAet al. Genetic variation at 16q24.2 is associated with small vessel stroke. Ann. Neurol.81(3), 383–394 (2017).
  • Kilarski LL , AchterbergS , DevanWJet al. Meta-analysis in more than 17,900 cases of ischemic stroke reveals a novel association at 12q24.12. Neurology83(8), 678–685 (2014).
  • Tregouet DA , HeathS , SautNet al. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood113(21), 5298–5303 (2009).
  • Maurano MT , HumbertR , RynesEet al. Systematic localization of common disease-associated variation in regulatory DNA. Science337(6099), 1190–1195 (2012).
  • Stratton MS , FarinaFM , EliaL. Epigenetics and vascular diseases. J. Mol. Cell Cardiol.133, 148–163 (2019).
  • Ng GY , LimYA , SobeyCG , DheenT , FannDY , ArumugamTV. Epigenetic regulation of inflammation in stroke. Ther. Adv. Neurol. Disord.11, 1756286418771815 (2018).
  • Qureshi IA , MehlerMF. The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine. Arch. Neurol.68(3), 294–302 (2011).
  • Brodie A , AzariaJR , OfranY. How far from the SNP may the causative genes be?Nucleic Acids Res.44(13), 6046–6054 (2016).
  • Pelikan RC , KellyJA , FuYet al. Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks. Nat. Commun.9(1), 2905 (2018).
  • Poppenberg KE , ZebraskiHR , AvasthiNet al. Epigenetic landscapes of intracranial aneurysm risk haplotypes implicate enhancer function of endothelial cells and fibroblasts in dysregulated gene expression. BMC Med. Genomics14(1), 162 (2021).
  • Poppenberg KE , JiangK , TsoMKet al. Epigenetic landscapes suggest that genetic risk for intracranial aneurysm operates on the endothelium. BMC Med. Genomics12(1), 149 (2019).
  • Malik R , ChauhanG , TraylorMet al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat. Genet50(4), 524–537 (2018).
  • Arnold M , RafflerJ , PfeuferA , SuhreK , KastenmüllerG. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics31(8), 1334–1336 (2014).
  • Yang C , HawkinsKE , DoreS , Candelario-JalilE. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am. J. Physiol. Cell Physiol.316(2), C135–C153 (2019).
  • Jiang K , ZhuL , BuckMJet al. Disease-associated single-nucleotide polymorphisms from noncoding regions in juvenile idiopathic arthritis are located within or adjacent to functional genomic elements of human neutrophils and CD4+ T cells. Arthritis Rheumatol.67(7), 1966–1977 (2015).
  • Alexander RP , FangG , RozowskyJ , SnyderM , GersteinMB. Annotating non-coding regions of the genome. Nat. Rev. Genet11(8), 559–571 (2010).
  • Gasperini M , HillAJ , Mcfaline-FigueroaJLet al. A genome-wide framework for mapping gene regulation via cellular genetic screens. Cell176(6), 1516 (2019).
  • Durand NC , RobinsonJT , ShamimMSet al. Juicebox provides a visualization system for Hi-C contact maps with unlimited zoom. Cell Syst.3(1), 99–101 (2016).
  • Wang W , TangY , WangYet al. LNK/SH2B3 loss of function promotes atherosclerosis and thrombosis. Circ. Res.119(6), e91–e103 (2016).
  • Rao SS , HuntleyMH , DurandNCet al. A 3D map of the human genome at kilobase resolution reveals principles of chromatin looping. Cell159(7), 1665–1680 (2014).
  • Theofilatos K , KorfiatiA , MavroudiS , CowperthwaiteMC , ShpakM. Discovery of stroke-related blood biomarkers from gene expression network models. BMC Med. Genomics12(1), 118 (2019).
  • Igolkina AA , ZinkevichA , KarandashevaKOet al. H3K4me3, H3K9ac, H3K27ac, H3K27me3 and H3K9me3histone tags suggest distinct regulatory evolution of open and condensed chromatin landmarks. Cells8(9), 1034 (2019).
  • Shamis Y , SilvaEA , HewittKJet al. Fibroblasts derived from human pluripotent stem cells activate angiogenic responses in vitro and in vivo. PLoS One8(12), e83755 (2013).
  • Xu L , YaoY. Central nervous system fibroblast-like cells in stroke and other neurological disorders. Stroke52(7), 2456–2464 (2021).
  • Dordoe C , ChenK , HuangWet al. Roles of fibroblast growth factors and their therapeutic potential in treatment of ischemic stroke. Front.Pharmacol.12(853), 671131 (2021).
  • Sweeney MD , KislerK , MontagneA , TogaAW , ZlokovicBV. The role of brain vasculature in neurodegenerative disorders. Nat. Neurosci.21(10), 1318–1331 (2018).
  • Roquer J , SeguraT , SerenaJ , CastilloJ. Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis.27(Suppl. 1), 25–37 (2009).
  • Joutel A , CorpechotC , DucrosAet al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature383(6602), 707–710 (1996).
  • Weinl C , CastanedaVega S , RiehleHet al. Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke. Proc. Natl Acad. Sci. USA112(32), 9914–9919 (2015).
  • Dardiotis E , AloizouAM , MarkoulaSet al. Cancer-associated stroke: pathophysiology, detection and management (Review). Int. J. Oncol.54(3), 779–796 (2019).
  • Navi BB , KasnerSE , ElkindMSV , CushmanM , BangOY , DeangelisLM. Cancer and embolic stroke of undetermined source. Stroke52(3), 1121–1130 (2021).
  • Chene P . Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat. Rev. Cancer3(2), 102–109 (2003).
  • Wei Y , SunZ , WangYet al. Methylation in the TP53 promoter is associated with ischemic stroke. Mol. Med. Rep.20(2), 1404–1410 (2019).
  • Vecino R , BurgueteMC , Jover-MengualTet al. The MDM2-p53 pathway is involved in preconditioning-induced neuronal tolerance to ischemia. Scientific Reports8(1), 1610 (2018).
  • Rodriguez C , Ramos-AraqueME , Dominguez-MartinezMet al. Single-nucleotide polymorphism 309T>G in the MDM2 promoter determines functional outcome after stroke. Stroke49(10), 2437–2444 (2018).
  • Meloche S , PouysségurJ. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene26(22), 3227–3239 (2007).
  • Sun J , NanG. The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: a potential therapeutic target (Review). Int. J. Mol. Med.39(6), 1338–1346 (2017).
  • Sawe N , SteinbergG , ZhaoH. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J. Neurosci. Res.86(8), 1659–1669 (2008).
  • Mostajeran M , EdvinssonL , WarfvingeK , SinghR , AnsarS. Inhibition of mitogen-activated protein kinase 1/2 in the acute phase of stroke improves long-term neurological outcome and promotes recovery processes in rats. Acta Physiol. (Oxf.)219(4), 814–824 (2017).
  • Koh SH , LoEH. The role of the PI3K pathway in the regeneration of the damaged brain by neural stem cells after cerebral infarction. J. Clin. Neurol.11(4), 297–304 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.